| http://dbpedia.org/ontology/abstract
|
AbCellera Biologics Inc. is a Vancouver, B … AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies. The company is best known for its leading role in the , a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.ped at the University of British Columbia.
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/British_Columbia +
, http://dbpedia.org/resource/Vancouver +
|
| http://dbpedia.org/ontology/numberOfEmployees
|
386
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_Company +
|
| http://dbpedia.org/ontology/wikiPageID
|
63128765
|
| http://dbpedia.org/ontology/wikiPageLength
|
10767
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1099865606
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/University_of_British_Columbia +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Canada +
, http://dbpedia.org/resource/Vancouver +
, http://dbpedia.org/resource/Antibody +
, http://dbpedia.org/resource/Pfizer +
, http://dbpedia.org/resource/Eli_Lilly_and_Company +
, http://dbpedia.org/resource/British_Columbia +
, http://dbpedia.org/resource/Series_B_round +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Bill_&_Melinda_Gates_Foundation +
, http://dbpedia.org/resource/Public_Company +
, http://dbpedia.org/resource/Teva_Pharmaceutical_Industries +
, http://dbpedia.org/resource/Tuberculosis +
, http://dbpedia.org/resource/Series_A_round +
, http://dbpedia.org/resource/Ablynx +
, http://dbpedia.org/resource/Messenger_RNA +
, http://dbpedia.org/resource/Biological_Technologies_Office_%28DARPA%29 +
, http://dbpedia.org/resource/Category:Companies_based_in_Vancouver +
, http://dbpedia.org/resource/COVID-19 +
, http://dbpedia.org/resource/Vancouver%2C_British_Columbia +
, http://dbpedia.org/resource/Respiratory_syncytial_virus +
, http://dbpedia.org/resource/Monoclonal_antibodies +
, http://dbpedia.org/resource/Gilead_Sciences +
, http://dbpedia.org/resource/Merck_&_Co. +
, http://dbpedia.org/resource/GlaxoSmithKline +
, http://dbpedia.org/resource/LY-CoV555 +
, http://dbpedia.org/resource/Pandemic_Prevention_Platform +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Moderna +
, http://dbpedia.org/resource/Category:Canadian_companies_established_in_2012 +
, http://dbpedia.org/resource/Emergency_Use_Authorization +
, http://dbpedia.org/resource/Food_and_Drug_Administration +
, http://dbpedia.org/resource/DARPA +
, http://dbpedia.org/resource/Variants_of_SARS-CoV-2 +
, http://dbpedia.org/resource/Peter_Thiel +
, http://dbpedia.org/resource/Monoclonal_antibody_therapy +
, http://dbpedia.org/resource/Sanofi +
, http://dbpedia.org/resource/Novartis +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/location
|
http://dbpedia.org/resource/British_Columbia +
, http://dbpedia.org/resource/Vancouver +
|
| http://dbpedia.org/property/name
|
AbCellera Biologics Inc.
|
| http://dbpedia.org/property/numEmployees
|
386
|
| http://dbpedia.org/property/revenue
|
375200000
|
| http://dbpedia.org/property/tradedAs
|
NASDAQ:ABCL
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_Company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Use_Canadian_English +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Vancouver_Corporations +
, http://dbpedia.org/resource/Template:Short_description +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Canadian_companies_established_in_2012 +
, http://dbpedia.org/resource/Category:Companies_based_in_Vancouver +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Canada +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/AbCellera?oldid=1099865606&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/AbCellera +
|
| http://xmlns.com/foaf/0.1/name
|
AbCellera Biologics Inc.
|
| owl:sameAs |
http://www.wikidata.org/entity/Q30271491 +
, http://dbpedia.org/resource/AbCellera +
, https://global.dbpedia.org/id/2oV7C +
|
| rdf:type |
http://dbpedia.org/ontology/Organisation +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/ontology/Company +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://schema.org/Organization +
|
| rdfs:comment |
AbCellera Biologics Inc. is a Vancouver, B … AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies. The company is best known for its leading role in the , a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.ped at the University of British Columbia.
|
| rdfs:label |
AbCellera
|
